FLGT Q4 2022 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

Q4 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$68M-73.1% YoY

Gross Profit

$13M19.2% margin

Operating Income

-$37M-54.0% margin

Net Income

-$24M-35.2% margin

EPS (Diluted)

$-0.80

QoQ Revenue Growth

-35.9%

Cash Flow

Operating Cash Flow

$33M

Free Cash Flow

$28M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$116M

Stockholders' Equity

$1.3B

Cash & Equivalents

$80M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$68M	$252M	-73.1%
Gross Profit	$13M	$190M	-93.1%
Operating Income	-$37M	$151M	-124.2%
Net Income	-$24M	$104M	-122.8%

Geographic Segments

UNITED STATES

$380M98%

Non-US

$8M2%